Every material Form 8-K Kimball Electronics, Inc. has filed with the SEC since July 01, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Kimball Electronics reported first-quarter fiscal 2027 net sales of $390.8 million, up 7% from a year earlier, with organic growth of 3% and Medical sales up 14%. Profit fell sharply, with diluted EPS of $0.11 versus $0.40 and operating income of $12.4 million versus $14.5 million. The company reiterated fiscal 2027 guidance and now expects sales at the high end of its $1,535 million to $1,560 million range.
Net sales were $390.8 million, up 7% from $365.6 million a year earlier; organic growth was 3%.
Medical sales rose 14% to $115.7 million, with 9% organic growth; the Helvoet acquisition contributed $12.4 million in net sales.
Operating income was $12.4 million versus $14.5 million; net income was $2.6 million versus $10.1 million.
Diluted EPS was $0.11 versus $0.40; adjusted diluted EPS was $0.25 versus $0.49. Fiscal 2027 sales are expected at the high end of $1,535 million to $1,560 million.
Kimball Electronics reported fourth-quarter fiscal 2026 net sales of $371.6 million, down 2% from a year earlier but up 5% from the prior quarter. Adjusted diluted EPS was a loss of $0.01, compared with $0.34 a year earlier, while GAAP diluted EPS rose to $0.35 from $0.26, helped by a $15.0 million gain on disposal. The company guided fiscal 2027 net sales of $1,535 million to $1,560 million, which includes about $60 million from the Helvoet acquisition.
Q4 net sales $371.6 million vs. $380.5 million a year earlier; adjusted operating income $18.1 million vs. $19.6 million
Q4 GAAP diluted EPS $0.35 vs. $0.26; adjusted diluted EPS $(0.01) vs. $0.34
Fiscal 2026 net sales $1,431.4 million, down 4% from $1,486.7 million; adjusted diluted EPS $1.09 vs. $1.12
Fiscal 2027 guidance: net sales $1,535 million to $1,560 million (7% to 9% growth) and adjusted operating income of 4.4% to 4.7% of net sales
Kimball Electronics completed its acquisition of Helvoet Polymer Technologies, a European contract development and manufacturing firm with operations in India, on July 1, 2026. The purchase price was €90 million, or about $103 million, funded with cash and existing credit lines. The company expects the deal to be accretive to fiscal 2027 adjusted earnings and to increase sales in its medical vertical by a low double-digit percentage.
Purchase price of €90 million (about $103 million), subject to post-closing working capital adjustments; €1.8 million held in escrow
Helvoet calendar 2025 revenue of approximately $56 million, with over 70% from medical customers
Price represents about 9x estimated Helvoet adjusted EBITDA for calendar 2026
Management webcast scheduled for Wednesday, July 1, 2026, at 9:00 AM ET
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Kimball Electronics, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →